G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/50 (2006.01)
Patent
CA 2642419
The invention provides methods of identifying metastatic disease as well as ligands such as antibodies that bind to GPR30. These antibodies are useful in the detection or treatment of endocrine tumors.
L'invention concerne des procédés permettant d'identifier une maladie métastatique ainsi que des ligands tels que des anticorps qui se lient à GPR30. Ces anticorps sont utiles dans la détection ou le traitement de tumeurs endocrines.
Filardo Edward J.
Sabo Edmond
Filardo Edward J.
Mbm Intellectual Property Law Llp
Rhode Island Hospital
Sabo Edmond
LandOfFree
Gpr30 estrogen receptor in breast cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gpr30 estrogen receptor in breast cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gpr30 estrogen receptor in breast cancers will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1897931